✦ LIBER ✦

Multiple dose trial of the thromboxane synthase inhibitor furegrelate in normal subjects

✍ Scribed by J. S. Mohrland; J. T. Vander Lugt; D. B. Lakings

Book ID: 105537607
Publisher: Springer
Year: 1990
Tongue: English
Weight: 408 KB
Volume: 38
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf02336688

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic and pharmacodynamic stud

Pharmacokinetic and pharmacodynamic studies following single and multiple doses of rolafagrel, a novel inhibitor of thromboxane synthase, in normal volunteers

✍ G. Gatti; A. Bartoli; E. Perucca; D. Bertin; M. Strolin-Benedetti 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 598 KB

Multiple-dose clinical pharmacology of t

Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjects

✍ J. Dingemanse; K. Jorga; G. Zürcher; B. Fotteler; G. Sedek; T. Nielsen; P. van B 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 391 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-6 inhibitor lazabemide in healthy subjects

✍ Jasper Dingemanse; Nolan Wood; Karin Jorga; Rolf Kettler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

Effects of the Src kinase inhibitor sara

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

✍ Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 243 KB